Vaccine Implementation and Impact

Who we are

We aim to be highly complementary and collaborative with other theme/s focusing on pathogens, AMR, and immunology / immunity, aiming NOT to replicate their areas of activity but to go for synergy.

The same would go for human experimental CHIM work.

What we (will) do :

• leveraging and building added scientific value from our activities and networks to attract and lead larger collaborative grants and consortia in these areas
• supporting training and capacity development